Clinical pharmacology: the European challenge
AbstractReports the results of a survey on the academic status of clinical pharmacology in the medical schools and health ministries of 21 European countries. The book opens with three articles assessing the status of clinical pharmacology in Europe. These articles discuss the main functions of clinical pharmacology in the national health system, patient care, teaching and research, describe basic principles for the teaching of clinical pharmacology and the training of specialists, and propose measures that can help bring the expertise of clinical pharmacology into routine medical care. The advantages of establishing clinical pharmacology as a permanent discipline in medical schools are also presented and explained. The main contributions of clinical pharmacology are identified as improving the scientific basis of therapeutic decisions, encouraging the individualization of drug therapy, and improving the research component of drug development. The main part of the book consists of brief reports on the organization and teaching of clinical pharmacology in the medical schools of each of 21 European countries. Points covered include the recognition of clinical pharmacology as a specialty, number of posts and departments, future plans, and national associations.
World Health Organization. Regional Office for Europe. (1991). Clinical pharmacology: the European challenge. World Health Organization. Regional Office for Europe. http://www.who.int/iris/handle/10665/260454
WHO regional publications. European series;39
Descriptionviii, 84 p.
MetadataShow full item record
Showing items related by title and MeSH subject.
Clinical pharmacological evaluation in drug control : ensuring quality of clinical trials : report from the 19th European Symposium, Bad Neuenahr, Germany 12-13 December 1995 European Symposium on Clinical Pharmacological Evaluation in Drug Control (19th: 1995: Bad Neuenahr, Germany); World Health Organization. Regional Office for Europe (EUR/ICP/DRVE 94 01/MT 01, 1996)Clinical trials are an essential step in the development of safe and efficacious new drugs. Registration of new drugs in future could depend on mutual recognition of such trials. They must therefore be of high quality and adhere to high ethical standards. This can be assured through the application of good clinical practice procedures incorporating strict requirements for ethical conduct, quality assessment and high scientific standards. The personal rights of volunteers and patients in clinical trials must be protected. Countries with no experience ...